Sun Pharmaceutical Industries’
subsidiary has been granted the US Food and Drug Administration (USFDA) final
approval for its Abbreviated New Drug Applications (ANDA) for generic version
of Prevacid, Lansoprazole Delayed-Release Capsules USP, 15 mg and 30 mg. Monday, September 16, 2013
Epic Update : Sun Pharmaceutical Industries
Sun Pharmaceutical Industries’
subsidiary has been granted the US Food and Drug Administration (USFDA) final
approval for its Abbreviated New Drug Applications (ANDA) for generic version
of Prevacid, Lansoprazole Delayed-Release Capsules USP, 15 mg and 30 mg. 
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment